Literature DB >> 20221679

The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy.

Mark J W McPhail1, Simon D Taylor-Robinson.   

Abstract

Hepatic encephalopathy (HE) is a diverse manifestation of acute and chronic liver failure, ranging from cognitive impairment, only detectable on psychometric evaluation through to confusion, coma and death from cerebral oedema. While there is widespread acceptance of its importance, there is little consensus on how best to diagnose and monitor HE. Clinical descriptions, psychometric testing, electroencephalography and magnetic resonance (MR) imaging (and lately, MR spectroscopy) have all been proposed. MR techniques, in contrast to other modalities, have the benefit of objectivity and of being able to interrogate the brain directly with respect to changes in brain size, function and the metabolic disturbances thought to underlie HE, particularly in the context of astrocyte swelling. Modern clinical MRI scanners with multinuclear MR spectroscopy capabilities and brain mapping software can demonstrate structural and functional cellular changes using volumetric MRI, magnetization transfer MRI, diffusion-weighting MRI, functional MRI with oxygenation measurements and in vivo and in vitro (1)H and (31)P MR spectroscopy. This review describes the relative merits of these techniques and provides guidance on the directions for future research and translation into clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 20221679     DOI: 10.1007/s11011-010-9171-4

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  68 in total

1.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

2.  White matter fiber tractography via anisotropic diffusion simulation in the human brain.

Authors:  Ning Kang; Jun Zhang; Eric S Carlson; Daniel Gembris
Journal:  IEEE Trans Med Imaging       Date:  2005-09       Impact factor: 10.048

3.  Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: a quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt.

Authors:  Takeshi Fukuzawa; Shoichi Matsutani; Hitoshi Maruyama; Taro Akiike; Hiromitsu Saisho; Takamichi Hattori
Journal:  J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 4.029

4.  Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy.

Authors:  Ryosuke Sugimoto; Motoh Iwasa; Masayuki Maeda; Naohito Urawa; Hideaki Tanaka; Naoki Fujita; Yoshinao Kobayashi; Kan Takeda; Masahiko Kaito; Yoshiyuki Takei
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

Review 5.  Development and applications of in vivo clinical magnetic resonance spectroscopy.

Authors:  I J Cox
Journal:  Prog Biophys Mol Biol       Date:  1996       Impact factor: 3.667

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 7.  Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.

Authors:  R F Butterworth; L Spahr; S Fontaine; G P Layrargues
Journal:  Metab Brain Dis       Date:  1995-12       Impact factor: 3.584

8.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

9.  Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy.

Authors:  W Nolte; J Wiltfang; C G Schindler; K Unterberg; M Finkenstaedt; P D Niedmann; H Hartmann; G Ramadori
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

10.  Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

Authors:  Beatriz Mínguez; Juan Carlos García-Pagán; Jaume Bosch; Juan Turnes; Juli Alonso; Alex Rovira; Juan Córdoba
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

View more
  12 in total

Review 1.  Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy.

Authors:  L J Zhang; J Zhong; G M Lu
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

2.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

Review 3.  The role of microbiota in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Gut Microbes       Date:  2014-04-01

Review 4.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

5.  Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI.

Authors:  Xiao-Fei Lv; Min Ye; Lu-Jun Han; Xue-Lin Zhang; Pei-Qiang Cai; Gui-Hua Jiang; Ying-Wei Qiu; Shi-Jun Qiu; Yao-Pan Wu; Kai Liu; Zhen-Yin Liu; Pei-Hong Wu; Chuan-Miao Xie
Journal:  Metab Brain Dis       Date:  2013-07-09       Impact factor: 3.584

6.  Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.

Authors:  Manoj K Sarma; Amir Huda; Rajakumar Nagarajan; Charles H Hinkin; Neil Wilson; Rakesh K Gupta; Enrique Frias-Martinez; James Sayre; Barry Guze; Steven-Huy Han; M Albert Thomas
Journal:  Metab Brain Dis       Date:  2011-06-23       Impact factor: 3.584

7.  Globus pallidus MR signal abnormalities in children with chronic liver disease and/or porto-systemic shunting.

Authors:  Sylviane Hanquinet; Claire Morice; Delphine S Courvoisier; Vladimir Cousin; Mehrak Anooshiravani; Laura Merlini; Valérie A McLin
Journal:  Eur Radiol       Date:  2017-04-06       Impact factor: 5.315

8.  A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Patrick M Gillevet; Neeral R Patel; Vishwadeep Ahluwalia; Jason M Ridlon; Birgit Kettenmann; Christine M Schubert; Masoumeh Sikaroodi; Douglas M Heuman; Mary M E Crossey; Debulon E Bell; Philip B Hylemon; Panos P Fatouros; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2012-04-12       Impact factor: 3.584

Review 9.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

10.  Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Authors:  Vishwadeep Ahluwalia; James B Wade; Leroy Thacker; Kenneth A Kraft; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Iliana Bouneva; Puneet Puri; Velimir Luketic; Arun J Sanyal; Hochong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.